top of page

STERI-NEB IPRATROPIUM NEBULISER SOLUTION 250 mcg/ml

Product details

Registration number: SIN10039P

Classification: Prescription Only

Active ingredients: IPRATROPIUM BROMIDE

Strength: 250 mcg/ml

Dosage form: SOLUTION

Route: RESPIRATORY (INHALATION)

Registrant: TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

ATC code: R03BB01

HSA approval date: 17 September 1998

Manufacturer(s): IVAX PHARMACEUTICALS UK

Manufacturing country/countries: UNITED KINGDOM

What are the HSA registration number and classification for STERI-NEB IPRATROPIUM NEBULISER SOLUTION 250 mcg/ml?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN10039P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for STERI-NEB IPRATROPIUM NEBULISER SOLUTION 250 mcg/ml?

According to the HSA dataset updated 7 August 2026:

Active ingredients: IPRATROPIUM BROMIDE

Strength: 250 mcg/ml

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for STERI-NEB IPRATROPIUM NEBULISER SOLUTION 250 mcg/ml?

According to the HSA dataset updated 7 August 2026:

Dosage form: SOLUTION

Route: RESPIRATORY (INHALATION)

Source for this answer

Who is the recorded registrant for STERI-NEB IPRATROPIUM NEBULISER SOLUTION 250 mcg/ml?

According to the HSA dataset updated 7 August 2026:

Registrant: TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Source for this answer

Which manufacturers and countries are listed for STERI-NEB IPRATROPIUM NEBULISER SOLUTION 250 mcg/ml?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s): IVAX PHARMACEUTICALS UK

Manufacturing country/countries: UNITED KINGDOM

Source for this answer

Where can I look up STERI-NEB IPRATROPIUM NEBULISER SOLUTION 250 mcg/ml in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN10039P or the exact product name STERI-NEB IPRATROPIUM NEBULISER SOLUTION 250 mcg/ml. The general register link does not preselect this product.

Source for this answer

What are the source dates for this STERI-NEB IPRATROPIUM NEBULISER SOLUTION 250 mcg/ml record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this STERI-NEB IPRATROPIUM NEBULISER SOLUTION 250 mcg/ml record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN10039P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page